China’s Aim For Centralized Bidding Pressures Medical Device Industry
This article was originally published in The Gray Sheet
China’s county-level public hospitals may be required to participate in provincial bidding to purchase medical devices like stents and pacemakers, putting pricing pressure on multinationals such as Boston Scientific, Medtronic and Abbott Laboratories and domestic manufacturers like MicroPort Scientific.
You may also be interested in...
U.S. device companies dealing in Asia worry about Chinese firms stealing American manufacturers’ intellectual property, then selling knock-offs of American devices that look similar, but are not as safe, AdvaMed’s executive VP of global strategies Ralph Ives told a U.S.-China trade commission April 3.
The just-retired Commerce official Jeffrey Gren discusses the impact of globalization on the medical device industry, and the issues the sector is facing in China.
The just-retired Commerce official Jeffrey Gren discusses the impact of globalization on the medical device industry, and the issues the sector is facing in China, in an interview with “The Gray Sheet.” Gren retired from the U.S. Department of Commerce in January after decades of focusing on device and drug trade issues.